Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
US6432924B1 · kind B1 · utility
24Cited by
7References
103Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 28, 2000 |
| Grant date | Aug 13, 2002 |
| Priority date | — |
| Expiry date | Jan 28, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition, device, kit and method for countering or diagnosing cytidine deaminase or deoxycytidine deaminase over-expression or a disorder associated with it, or an increase in number or toxicity of pro-inflammatory cells that over-express cytidine deaminase or deoxycytidine deaminase or a disorder associated with it, utilizing an agent of the formula C7N3H8O2R1R2XX1, wherein X and X1 are each independently C or N, R1 is lower alkyl, alkenyl and alkynyl, halogen or haloalkyl, and R2 is H, —N3 —OH, amino or halogen; or pharmaceutically acceptable salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.